Jaqueline Mock

7PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsIndustrial molecular engineering of nucleic acids and proteinsNanofabrication, growth and self assembly
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2023
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties.

Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock

|Sep 28, 2021
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease.

Sheila Dakhel, Christian Lizak, Mattia Matasci

|Feb 26, 2021
A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.

Riccardo Corbellari, Marco Stringhini, Jaqueline Mock

|Nov 26, 2020
An engineered 4-1BBL fusion protein with "activity on demand".

Jacqueline Mock, Marco Stringhini, Alessandra Villa

|Feb 26, 2020
A universal reporter cell line for bioactivity evaluation of engineered cytokine products.

Jacqueline Mock, Christian Pellegrino, Dario Neri

Pageof 2